MedinCell S.A. (MEDCL.PA)
EUR 13.78
(1.85%)
EUR 13.78
(1.85%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.88 EUR | 30.71% |
| 2022 | -1.27 EUR | -27.0% |
| 2021 | -1.00 EUR | -16.28% |
| 2020 | -0.86 EUR | 27.73% |
| 2019 | -1.19 EUR | -4.39% |
| 2018 | -1.14 EUR | -72.73% |
| 2017 | -0.66 EUR | -164.0% |
| 2016 | -0.25 EUR | -681.4% |
| 2015 | 0.04 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 FY | - EUR | 30.71% |
| 2023 Q2 | -0.29 EUR | 0.0% |
| 2023 Q4 | -0.58 EUR | 0.0% |
| 2022 Q2 | -0.55 EUR | 0.0% |
| 2022 Q4 | -0.72 EUR | 0.0% |
| 2022 FY | - EUR | -27.0% |
| 2021 Q2 | -0.47 EUR | 0.0% |
| 2021 Q4 | -0.52 EUR | 0.0% |
| 2021 FY | - EUR | -16.28% |
| 2020 FY | - EUR | 27.73% |
| 2020 Q4 | -0.33 EUR | 0.0% |
| 2020 Q2 | -0.50 EUR | 0.0% |
| 2019 Q4 | -0.74 EUR | 0.0% |
| 2019 FY | - EUR | -4.39% |
| 2019 Q2 | -0.45 EUR | 0.0% |
| 2018 Q4 | -0.49 EUR | -96.0% |
| 2018 Q3 | -0.25 EUR | 63.24% |
| 2018 Q1 | -0.34 EUR | -3.03% |
| 2018 Q2 | -0.68 EUR | -100.0% |
| 2018 FY | - EUR | -72.73% |
| 2017 Q2 | -0.34 EUR | -100.0% |
| 2017 Q4 | -0.33 EUR | -106.25% |
| 2017 FY | - EUR | -164.0% |
| 2017 Q3 | -0.16 EUR | 52.94% |
| 2017 Q1 | -0.17 EUR | 0.0% |
| 2016 FY | - EUR | -681.4% |
| 2015 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -633.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 74.344% |
| Adocia SA | -1.91 EUR | 53.927% |
| Aelis Farma SA | -0.39 EUR | -125.641% |
| Biophytis S.A. | -12.55 EUR | 92.988% |
| Advicenne S.A. | -0.67 EUR | -31.343% |
| genOway Société anonyme | 0.17 EUR | 617.647% |
| IntegraGen SA | -0.03 EUR | -3297.683% |
| Medesis Pharma S.A. | -0.80 EUR | -10.0% |
| Neovacs S.A. | -0.00 EUR | -35100.0% |
| NFL Biosciences SA | -0.46 EUR | -91.304% |
| Plant Advanced Technologies SA | 0.07 EUR | 1357.143% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -867.033% |
| Sensorion SA | -0.17 EUR | -417.647% |
| Theranexus Société Anonyme | -0.88 EUR | -0.0% |
| TME Pharma N.V. | -1.34 EUR | 34.328% |
| Valbiotis SA | -0.59 EUR | -49.153% |
| TheraVet SA | -0.49 EUR | -79.592% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -486.667% |
| DBV Technologies S.A. | -0.71 EUR | -23.944% |
| Genfit S.A. | -0.58 EUR | -51.724% |
| GeNeuro SA | -0.59 EUR | -49.153% |
| Innate Pharma S.A. | -0.09 EUR | -835.175% |
| Inventiva S.A. | -2.43 EUR | 63.786% |
| MaaT Pharma SA | -1.73 EUR | 49.133% |
| Nanobiotix S.A. | -1.08 EUR | 18.519% |
| OSE Immunotherapeutics SA | -1.18 EUR | 25.424% |
| Poxel S.A. | -0.91 EUR | 3.297% |
| GenSight Biologics S.A. | -0.54 EUR | -62.963% |
| Transgene SA | -0.22 EUR | -300.0% |
| Valneva SE | -0.73 EUR | -20.548% |